Savadori Lucia, Savio Stefania, Nicotra Eraldo, Rumiati Rino, Finucane Melissa, Slovic Paul
Dipartimento di Scienze della Cognizione e della Formazione, University of Trento, Italy.
Risk Anal. 2004 Oct;24(5):1289-99. doi: 10.1111/j.0272-4332.2004.00526.x.
Risk perceptions of a series of biotechnology applications were examined in a public (nonexpert) sample and an expert sample. Compared with the experts, the public perceived all biotechnology applications as more risky. Both groups perceived food-related applications to be riskier than medical applications. Compared with the public, experts perceived both food and medical applications as less harmful and more useful. Experts also judged the risks posed from medical biotechnology applications as more familiar and acknowledged by people and science. Lay estimates of the risk of food applications were predicted by potential harm, potential benefits, science knowledge, and familiarity; experts' estimates were predicted only by harm and benefits. Lay estimates of the risk of medical applications were predicted by potential harm; experts' estimates were predicted by potential benefits, number and type of people exposed, and science knowledge. We discuss the implications of the results for risk communication about and management of different types of biotechnologies.
在一个公众(非专业人士)样本和一个专家样本中,研究了对一系列生物技术应用的风险认知。与专家相比,公众认为所有生物技术应用的风险更高。两组都认为与食品相关的应用比医疗应用风险更大。与公众相比,专家认为食品和医疗应用的危害更小且更有用。专家还判断医疗生物技术应用带来的风险为人们和科学界更熟悉且认可的。公众对食品应用风险的估计由潜在危害、潜在益处、科学知识和熟悉程度预测;专家的估计仅由危害和益处预测。公众对医疗应用风险的估计由潜在危害预测;专家的估计由潜在益处、接触人群的数量和类型以及科学知识预测。我们讨论了这些结果对不同类型生物技术的风险沟通和管理的影响。